诊断后红肉、禽肉及蛋类摄入与前列腺癌进展及死亡风险的系统综述
该系统综述检索截至2025年7月17日的文献,纳入6项前瞻性队列研究、超过10,000名前列腺癌患者,评估诊断后红肉、禽肉及蛋类摄入与前列腺癌进展及全因死亡的关系。总体证据有限且不一致,全因死亡方面统计证据较强;红肉替换为去皮禽肉或鱼可能降低进展或死亡风险,带皮禽肉及较高蛋类摄入(>3-5份/周)可能与进展风险升高相关。
要点
- 红肉总摄入与进展无一致关联,但2项研究提示用禽肉或鱼替代红肉与较低进展或死亡风险相关。
- 带皮禽肉在2项研究中与较高进展风险相关(1项显著),去皮禽肉则无此关联。
- 蛋类摄入与进展的关联不一致,最高摄入约5.5份/周的研究显示正相关,摄入较低(≥2.5-3份/周)的研究未发现关联。
核心结论
- 诊断后红肉、禽肉及蛋类摄入与前列腺癌进展的证据有限且不一致,全因死亡的统计证据相对较强。
- 前列腺癌进展风险可能与制备方式(如带皮禽肉)及较高蛋类摄入(>3-5份/周)有关。
- 用去皮禽肉或鱼替代红肉可能带来临床获益。
研究设计与样本
- 系统综述,检索PubMed/MEDLINE、Web of Science和Embase截至2025年7月17日,无日期限制。
- 纳入6项前瞻性队列研究,合计超过10,000名前列腺癌患者。
- 由两名评价者独立筛选文献、提取数据并评估偏倚风险。
主要发现
- 5项研究中红肉总摄入与进展结局无关联,2项评估全因死亡的研究中1项报告正相关。
- 2项研究提示用禽肉或鱼替代红肉与较低进展或全因死亡风险相关。
- 1项研究报告加工红肉摄入与前列腺癌特异性死亡及全因死亡正相关,另4项研究无显著关联。
- 禽肉总摄入与进展无显著关联;带皮禽肉在2项研究中与较高风险相关(1项显著),去皮禽肉无关联;唯一评估禽肉与全因死亡的研究显示较低风险。
- 蛋类摄入与进展的关联不一致:最高摄入约5.5份/周的研究显示正相关,最高摄入≥2.5-3份/周的4项研究无关联;2项评估全因死亡的研究中1项显示正相关。
临床怎么用
- 对前列腺癌生存者,可考虑建议用去皮禽肉或鱼替代红肉以可能降低进展或死亡风险。
- 建议限制带皮禽肉及较高蛋类摄入(>3-5份/周),尤其对关注进展风险的患者。
- 加工红肉摄入可能与前列腺癌特异性死亡及全因死亡相关,应纳入饮食咨询。
局限性
- 纳入研究数量有限(6项队列),证据总体不一致。
- 蛋类摄入与进展的关联受最高摄入类别水平差异影响,结果不一致。
- 部分关联仅基于单项研究,需更多设计良好的前瞻性研究验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The purpose of this study was to systematically review evidence on associations of postdiagnostic consumption of red meat, poultry, and eggs with prostate cancer outcomes among men diagnosed with prostate cancer. METHODS: We searched PubMed/MEDLINE, Web of Science, and Embase through July 17, 2025, with no date restrictions. Eligible studies included prospective cohorts examining postdiagnostic consumption of red meat, poultry, and eggs in relation to prostate cancer progression (eg, biochemical recurrence, initiation of secondary treatment, metastases, and prostate cancer-specific mortality) and/or all-cause mortality (ACM) in men with prostate cancer. Two reviewers independently screened articles, extracted data, and assessed risk of bias. RESULTS: Six cohort studies including > 10,000 men with prostate cancer met inclusion criteria. Across 5 studies, total red meat consumption was not associated with progression outcomes, while 1 of 2 studies evaluating ACM reported a positive relationship. However, 2 studies indicated that replacement of red meat with poultry or fish was associated with lower risk of progression or ACM. One study reported a positive association between processed red meat intake and both prostate cancer-specific mortality and ACM, although 4 other studies reported no significant association. Total poultry intake was not significantly associated with progression. By contrast, poultry with skin was linked to higher risk in 2 studies (1 significant), whereas poultry without skin was not associated with progression. Poultry intake was associated with lower ACM risk in the only study evaluating this relationship. Evidence for egg consumption was inconsistent; a positive association with progression was observed in 1 study with especially high intake in the highest category (∼5.5 servings/week), whereas no associations were found in 4 studies where intakes were lower in the highest categories (≥ 2.5-3 servings/week). One out of 2 studies demonstrated a positive relationship with ACM. CONCLUSIONS: Evidence linking postdiagnostic intake of red meat, poultry, and eggs with prostate cancer progression remain limited and inconsistent, although stronger statistical evidence was observed for ACM. Prostate cancer progression risk may be specific to preparation methods (eg, poultry with skin) and higher egg intake (> 3-5 servings/week), while replacing red meat with skinless poultry or fish may offer clinical benefit. Additional well-designed prospective studies are needed.
引用
- Sandhu S, Teshome H, Van Blarigan EL, et al. Postdiagnostic Red Meat, Poultry, and Egg Intake and Risk of Prostate Cancer Progression and Mortality: A Systematic Review. J Urol. 2026. PMID: 42607142. doi:10.1097/JU.0000000000005263
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。